Benchling: AlphaFold beta feature
R&D cloud technology company Benchling has launched its AlphaFold beta feature. The AI platform, used to predict the 3D structure of a protein, is intended to help users overcome some of the challenges associated with implementation, computing power, and resourcing.
“Our team gets excited about two things: science and bringing software to science,” said Ashu Singhal, president and co-founder of Benchling. “By making AlphaFold available to the biotech industry at the click of a button, scientists will be able to seamlessly experiment with this exciting advancement and find new ways to leverage AlphaFold output in their research.”
